VKTX

Healthcare

Viking Therapeutics, Inc.

$35.73+0.26 (+0.73%)

Prev Close

$35.47

Open

$35.95

High

$37.50

Low

$35.45

Volume

2.17M

Market Cap

$3.88B

P/E

—

Div Yield

—

Over the past 12 months, insider activity at Viking Therapeutics, Inc. (VKTX) has been dominated by selling, with 2 insider purchases totaling $179.9K and 15 insider sales totaling $29.02M. The most recent insider transaction was by Aubuchon Neil William (officer: Chief Commercial Officer), who purchased $149.9K worth of shares on Mar 10, 2026. Viking Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $3.88B.

Buys (12M)

$179.9K

Sells (12M)

$29.02M

Net Activity

Net Seller

$28.84M

Active Insiders

last 12 mo

VKTX Price Chart

VKTX Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 10, 2026↗	Aubuchon Neil William	officer: Chief Commercial Officer	Buy	4,475	$33.50	$149.9K	4,475
Jan 5, 2026↗	FOEHR MATTHEW W	director	Sell	16,000	$35.11	$561.7K	132,036
Jan 5, 2026↗	Lian Brian	director, officer: President & CEO	Sell	233,409	$32.96	$7.69M	2,600,250
Jan 5, 2026↗	Mancini Marianna	officer: Chief Operating Officer	Sell	57,661	$32.98	$1.90M	434,890
Jan 5, 2026↗	ZANTE GREG	officer: Chief Financial Officer	Sell	57,661	$32.90	$1.90M	215,571
Jan 2, 2026↗	FOEHR MATTHEW W	Director	Sell	16,000	$35.11	$561.7K	0
Jan 2, 2026↗	Lian Brian	President & CEO	Sell	233,409	$32.96	$7.69M	0
Jan 2, 2026↗	Mancini Marianna	Chief Operating Officer	Sell	57,661	$32.98	$1.90M	0
Jan 2, 2026↗	ZANTE GREG	Chief Financial Officer	Sell	57,661	$32.90	$1.90M	0
Oct 27, 2025↗	Lian Brian	President & CEO	Sell	38,989	$35.01	$1.36M	0
Oct 27, 2025↗	Mancini Marianna	Chief Operating Officer	Sell	6,185	$35.00	$216.5K	0
Oct 27, 2025↗	Rowland Charles A Jr	Director	Sell	60,000	$35.57	$2.13M	0
Oct 27, 2025↗	ZANTE GREG	Chief Financial Officer	Sell	6,185	$35.00	$216.5K	0
Jul 2, 2025↗	Lian Brian	President & CEO	Sell	26,889	$27.80	$747.6K	0
Jul 2, 2025↗	Mancini Marianna	Chief Operating Officer	Sell	4,266	$27.77	$118.5K	0
Jul 2, 2025↗	ZANTE GREG	Chief Financial Officer	Sell	4,266	$27.76	$118.4K	0
Mar 31, 2025↗	Rouan Sarah Kathryn	Director	Buy	1,240	$24.15	$29.9K	0

VKTX Insider Buying Activity

The following table shows recent insider purchases of Viking Therapeutics, Inc. (VKTX) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 10, 2026↗	Aubuchon Neil William	officer: Chief Commercial Officer	Buy	4,475	$33.50	$149.9K	4,475
Mar 31, 2025↗	Rouan Sarah Kathryn	Director	Buy	1,240	$24.15	$29.9K	0

VKTX Insider Selling Activity

The following table shows recent insider sales of Viking Therapeutics, Inc. (VKTX) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jan 5, 2026↗	FOEHR MATTHEW W	director	Sell	16,000	$35.11	$561.7K	132,036
Jan 5, 2026↗	Lian Brian	director, officer: President & CEO	Sell	233,409	$32.96	$7.69M	2,600,250
Jan 5, 2026↗	Mancini Marianna	officer: Chief Operating Officer	Sell	57,661	$32.98	$1.90M	434,890
Jan 5, 2026↗	ZANTE GREG	officer: Chief Financial Officer	Sell	57,661	$32.90	$1.90M	215,571
Jan 2, 2026↗	FOEHR MATTHEW W	Director	Sell	16,000	$35.11	$561.7K	0
Jan 2, 2026↗	Lian Brian	President & CEO	Sell	233,409	$32.96	$7.69M	0
Jan 2, 2026↗	Mancini Marianna	Chief Operating Officer	Sell	57,661	$32.98	$1.90M	0
Jan 2, 2026↗	ZANTE GREG	Chief Financial Officer	Sell	57,661	$32.90	$1.90M	0
Oct 27, 2025↗	Lian Brian	President & CEO	Sell	38,989	$35.01	$1.36M	0
Oct 27, 2025↗	Mancini Marianna	Chief Operating Officer	Sell	6,185	$35.00	$216.5K	0
Oct 27, 2025↗	Rowland Charles A Jr	Director	Sell	60,000	$35.57	$2.13M	0
Oct 27, 2025↗	ZANTE GREG	Chief Financial Officer	Sell	6,185	$35.00	$216.5K	0
Jul 2, 2025↗	Lian Brian	President & CEO	Sell	26,889	$27.80	$747.6K	0
Jul 2, 2025↗	Mancini Marianna	Chief Operating Officer	Sell	4,266	$27.77	$118.5K	0
Jul 2, 2025↗	ZANTE GREG	Chief Financial Officer	Sell	4,266	$27.76	$118.4K	0